Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

One-year progression of CT emphysema subtypes predict lung function decline: SPIROMICS.

One-year progression of CT emphysema subtypes predicted accelerated FEV₁ decline, supporting their potential use as intermediate endpoints in COPD trials and evaluating associations between one-year QCT measure changes and FEV₁ decline from visits two through five.

Emilia A. Hermann, E. Hoffman, Elsa D. Angelini et al. · 0 citations
Aug 2026

Associations Between Glucagon-like Peptide-1 Receptor Agonists and Respiratory Outcomes in Chronic Obstructive pulmonary disease and Diabetes.

BACKGROUND Chronic obstructive pulmonary disease (COPD) is frequently complicated by acute respiratory failure, pneumonia, exacerbations, and premature mortality, particularly in patients with comorbid type 2 diabetes (T2D). Glucagon-like peptide-1 receptor agonists (GLP-1RAs) possess anti-inflammatory and metabolic pr...

Kuang-Ming Liao, Ya-Wen Tsai, K. Kostikas et al. · 0 citations
Open access Aug 2026

Metabolomic profiling reveals distinct and shared biology in COPD and IPF

Alterations in metabolomic profiles of COPD and IPF suggested shared dysregulation of several lipids, however, some metabolites pointed to disease-specific differences.

Aldric Rosario, N. Prince, S. Madha-Krause et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.